Abstract:Amyloid β-peptide (Aβ) aggregation induced by metal ions such as Cu2+ has been recognized as a crucial step in the pathogenesis of Alzheimer's disease (AD), so development of multifunctional agents that are able to inhibit Aβ aggregation and modulate Cu2+-Aβ species is considered as a promising strategy for fighting against AD. Our recent work proved that basification of human lysozyme (hLys) is in favor of enhancing the inhibition of Aβ aggregation. Based on the finding, we have herein designed R-hLys, a conjugate of bifunctional alkaline decapeptide (RTHLVFFARK, RK10) coupled onto hLys via reaction with the carboxyl groups on hLys. The design created an even more basic protein than hLys, thus increasing the potency of hLys on inhibiting Aβ fibrillation. Moreover, the RK10 conjugation onto hLys introduced a specific Cu2+-chelator and an additional peptide inhibitor (LVFFARK). Thus, a multifunctional modulator on Cu2+-mediated Aβ aggregation and cytotoxicity was developed. The multifunctional effects of R-hLys were systematically investigated on Aβ aggregation, Cu2+-mediated Aβ aggregation, ROS production, and remodeling mature Aβ species by comparison to its counterparts. The results revealed the following: (1) R-hLys possesses high potency on inhibiting Aβ fibrillogenesis; R-hLys at 1/5 to 1/4 of hLys concentration works similarly to hLys. (2) R-hLys exhibits high performance on inhibiting Cu2+-induced Aβ aggregation and cytotoxicity; it increased the cell viability from 48.9% to 86.1% at an equimolar concentration to Aβ. (3) R-hLys arrests the production of reactive oxygen species catalyzed by Cu2+ or Cu2+-Aβ42 species. (4) R-hLys remodels mature Aβ42 fibrils and Cu2+-Aβ42 aggregates into small amorphous aggregates of lower cytotoxicity; by co-incubation with R-hLys, the cytotoxicities of mature Aβ42 fibrils and Cu2+-Aβ42 aggregates are reduced from 31.4% to 14.2% and 48.1% to 10.4%, respectively. Taken together, R-hLys is a potent multifunctional modulator for inhibiting Aβ/Cu2+-mediated-Aβ aggregation, suppressing ROS production and remodeling mature Aβ42/Cu2+-Aβ42 species.

LVFFARK Conjugation to Poly (carboxybetaine Methacrylate) Remarkably Enhances Its Inhibitory Potency on Amyloid Β-Protein Fibrillogenesis

Ac-LVFFARK-NH2 Conjugation to Β-Cyclodextrin Exhibits Significantly Enhanced Performance on Inhibiting Amyloid Β-Protein Fibrillogenesis and Cytotoxicity.

Unexpected Function Of A Heptapeptide-Conjugated Zwitterionic Polymer That Coassembles Into Beta-Amyloid Fibrils And Eliminates The Amyloid Cytotoxicity

Design of LVFFARK and LVFFARK-Functionalized Nanoparticles for Inhibiting Amyloid Β-Protein Fibrillation and Cytotoxicity

Carnosine-LVFFARK-NH2 Conjugate: A Moderate Chelator but Potent Inhibitor of Cu2+-Mediated Amyloid β-Protein Aggregation.

Head-to-tail Cyclization of a Heptapeptide Eliminates Its Cytotoxicity and Significantly Increases Its Inhibition Effect on Amyloid Β-Protein Fibrillation and Cytotoxicity

Chiral LVFFARK Enantioselectively Inhibits Amyloid-Β Protein Fibrillogenesis

Design of Nonapeptide LVFFARKHH: A Bifunctional Agent Against Cu2+‐mediated Amyloid Β‐protein Aggregation and Cytotoxicity

Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro

Conjugation of RTHLVFFARK to Human Lysozyme Creates a Potent Multifunctional Modulator for Cu2+-mediated Amyloid Β-Protein Aggregation and Cytotoxicity

Synthesis and Evaluation of Ferrocenoyl Pentapeptide (Fc-Klvff) As an Inhibitor of Alzheimer’s Aβ1–42 Fibril Formation in Vitro

Clvffa-Functionalized Gold Nanoclusters Inhibit A Beta 40 Fibrillation, Fibrils' Prolongation, And Mature Fibrils' Disaggregation

CLVFFA-Functionalized Gold Nanoclusters Inhibit Aβ40 Fibrillation, Fibrils’ Prolongation, and Mature Fibrils’ Disaggregation

LVFFARK-PEG-Stabilized Black Phosphorus Nanosheets Potently Inhibit Amyloid-β Fibrillogenesis.

RTHLVFFARK-NH2: A Potent and Selective Modulator on Cu2+-mediated Amyloid-Β Protein Aggregation and Cytotoxicity

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Self-Assembled Curcumin-Poly(carboxybetaine Methacrylate) Conjugates: Potent Nano-Inhibitors Against Amyloid Β-Protein Fibrillogenesis and Cytotoxicity.

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

Synthesis of Ferrocenoyl-Peptide and Its Inhibition for Beta-Amyloid Peptide

Kinetic Studies of Inhibition of the Amyloid Beta (1–42) Aggregation Using a Ferrocene-Tagged Β-Sheet Breaker Peptide

The Synergistic Effect Between KLVFF and Self-Assembly Chaperones on Both Disaggregation of Beta-Amyloid Fibrils and Reducing Consequent Toxicity.